These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29028998)

  • 21. Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.
    Meya DB; Manabe YC; Castelnuovo B; Cook BA; Elbireer AM; Kambugu A; Kamya MR; Bohjanen PR; Boulware DR
    Clin Infect Dis; 2010 Aug; 51(4):448-55. PubMed ID: 20597693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for cryptococcal antigen in asymptomatic people with HIV: urgent need in Eastern India.
    Chakravarty J; Reddy S; Gupta MK; Tilak R; Diwaker C; Sundar S
    AIDS; 2023 Dec; 37(15):2359-2363. PubMed ID: 37650766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.
    Ford N; Shubber Z; Jarvis JN; Chiller T; Greene G; Migone C; Vitoria M; Doherty M; Meintjes G
    Clin Infect Dis; 2018 Mar; 66(suppl_2):S152-S159. PubMed ID: 29514236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.
    McKenney J; Bauman S; Neary B; Detels R; French A; Margolick J; Doherty B; Klausner JD
    Clin Infect Dis; 2015 Mar; 60(6):959-65. PubMed ID: 25422390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis.
    Li Y; Huang X; Chen H; Qin Y; Hou J; Li A; Wu H; Yan X; Chen Y
    BMC Infect Dis; 2020 Jun; 20(1):410. PubMed ID: 32532212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of Reflex Cryptococcal Antigen (CrAg) Screening in Human Immunodeficiency Virus (HIV)-Positive Patients With CD4 Counts of 100-200 Cells/µL in Botswana.
    Tenforde MW; Milton T; Rulaganyang I; Muthoga C; Tawe L; Chiller T; Greene G; Jordan A; Williams CG; Owen L; Leeme TB; Boose A; Ngidi J; Mine M; Jarvis JN
    Clin Infect Dis; 2021 May; 72(9):1635-1638. PubMed ID: 32604411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts.
    Montgomery MP; Nakasujja N; Morawski BM; Rajasingham R; Rhein J; Nalintya E; Williams DA; Huppler Hullsiek K; Kiragga A; Rolfes MA; Donahue Carlson R; Bahr NC; Birkenkamp KE; Manabe YC; Bohjanen PR; Kaplan JE; Kambugu A; Meya DB; Boulware DR;
    BMC Neurol; 2017 Jun; 17(1):110. PubMed ID: 28606065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asymptomatic Cryptococcal Antigenemia in People Living with HIV (PLHIV) with Severe Immunosuppression: Is Routine CrAg Screening Indicated in India?
    Anuradha S; H AN; Dewan R; Kaur R; Rajeshwari K
    J Assoc Physicians India; 2017 Apr; 65(4):14-17. PubMed ID: 28527158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease.
    Tenforde MW; Boyer-Chammard T; Muthoga C; Tawe L; Milton T; Rulaganyang I; Lechiile K; Rukasha I; Leeme TB; Govender NP; Ngidi J; Mine M; Molloy SF; Harrison TS; Lortholary O; Jarvis JN
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Routine Cryptococcal Antigen Screening and Targeted Preemptive Fluconazole Therapy in Antiretroviral-naive Human Immunodeficiency Virus-infected Adults With CD4 Cell Counts <100/μL: A Systematic Review and Meta-analysis.
    Temfack E; Bigna JJ; Luma HN; Spijker R; Meintjes G; Jarvis JN; Dromer F; Harrison T; Cohen JF; Lortholary O
    Clin Infect Dis; 2019 Feb; 68(4):688-698. PubMed ID: 30020446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective cohort of AIDS patients screened for cryptococcal antigenaemia, pre-emptively treated and followed in Brazil.
    Borges MASB; de Araújo Filho JA; Oliveira BJS; Moreira IS; de Paula VV; de Bastos AL; Soares RBA; Turchi MD
    PLoS One; 2019; 14(7):e0219928. PubMed ID: 31344140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of prior cryptococcal antigen screening on in-hospital mortality in cryptococcal meningitis or fungaemia among HIV-seropositive individuals in South Africa: a cross-sectional observational study.
    Paccoud O; Shuping L; Mashau R; Greene G; Quan V; Meiring S; Govender NP;
    Clin Microbiol Infect; 2023 Aug; 29(8):1063-1069. PubMed ID: 37086780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications.
    Wake RM; Molloy SF; Jarvis JN; Harrison TS; Govender NP
    Clin Infect Dis; 2023 Feb; 76(4):764-770. PubMed ID: 35986670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryptococcal Meningitis Diagnostics and Screening in the Era of Point-of-Care Laboratory Testing.
    Rajasingham R; Wake RM; Beyene T; Katende A; Letang E; Boulware DR
    J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30257903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY.
    Vidal JE; Boulware DR
    Rev Inst Med Trop Sao Paulo; 2015 Sep; 57 Suppl 19(Suppl 19):38-45. PubMed ID: 26465368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia.
    Beyene T; Woldeamanuel Y; Asrat D; Ayana G; Boulware DR
    PLoS One; 2013; 8(10):e75585. PubMed ID: 24124498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation and Operational Research: Evaluation of a Public-Sector, Provider-Initiated Cryptococcal Antigen Screening and Treatment Program, Western Cape, South Africa.
    Vallabhaneni S; Longley N; Smith M; Smith R; Osler M; Kelly N; Cross A; Boulle A; Meintjes G; Govender NP
    J Acquir Immune Defic Syndr; 2016 Jun; 72(2):e37-e42. PubMed ID: 26926942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Accuracy of Point of Care Cryptococcal Antigen Lateral Flow Assay in Fingerprick Whole Blood and Urine Samples for the Detection of Asymptomatic Cryptococcal Disease in Patients with Advanced HIV Disease.
    Boyd K; Kouamou V; Hlupeni A; Tangwena Z; Ndhlovu CE; Makadzange AT;
    Microbiol Spectr; 2022 Aug; 10(4):e0107522. PubMed ID: 35924841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy-Experienced Ugandans With Virologic Failure.
    Mpoza E; Rajasingham R; Tugume L; Rhein J; Nabaggala MS; Ssewanyana I; Nyegenye W; Kushemererwa GE; Mulema V; Kalamya J; Kiyaga C; Kabanda J; Ssali M; Boulware DR; Meya DB
    Clin Infect Dis; 2020 Oct; 71(7):1726-1731. PubMed ID: 31679007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of cryptococcal antigen lateral flow assay in serum, cerebrospinal fluid, whole blood, and urine in HIV-infected patients with culture-proven cryptococcal meningitis admitted at a Brazilian referral center.
    Vidal JE; Toniolo C; Paulino A; Colombo AL; Martins MDA; Meira CDS; Azevedo RGS; Pereira-Chioccola VL; Gomes HR; Lazera MDS; Oliveira ACP; Boulware DR
    Rev Inst Med Trop Sao Paulo; 2018; 60():e1. PubMed ID: 29451598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.